APA (7th ed.) Citation

S, F., EM, L., PW, B., DL, K., N, N., S, H., . . . N, B. (2020). Favorable skeletal benefit/risk of long-term denosumab therapy: A virtual-twin analysis of fractures prevented relative to skeletal safety events observed. Bone, 134, 115287. https://doi.org/10.1016/j.bone.2020.115287

Chicago Style (17th ed.) Citation

S, Ferrari, et al. "Favorable Skeletal Benefit/risk of Long-term Denosumab Therapy: A Virtual-twin Analysis of Fractures Prevented Relative to Skeletal Safety Events Observed." Bone 134 (2020): 115287. https://doi.org/10.1016/j.bone.2020.115287.

MLA (9th ed.) Citation

S, Ferrari, et al. "Favorable Skeletal Benefit/risk of Long-term Denosumab Therapy: A Virtual-twin Analysis of Fractures Prevented Relative to Skeletal Safety Events Observed." Bone, vol. 134, 2020, p. 115287, https://doi.org/10.1016/j.bone.2020.115287.